These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8570172)

  • 1. CD44 hyaluronate binding influences growth kinetics and tumorigenicity of human colon carcinomas.
    Takahashi K; Stamenkovic I; Cutler M; Saya H; Tanabe KK
    Oncogene; 1995 Dec; 11(11):2223-32. PubMed ID: 8570172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-linked glycosylation modifies CD44 adhesion to hyaluronate in colon carcinoma cells.
    Dasgupta A; Takahashi K; Cutler M; Tanabe KK
    Biochem Biophys Res Commun; 1996 Oct; 227(1):110-7. PubMed ID: 8858111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.
    Liao HX; Levesque MC; Patton K; Bergamo B; Jones D; Moody MA; Telen MJ; Haynes BF
    J Immunol; 1993 Dec; 151(11):6490-9. PubMed ID: 7504022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells.
    Sleeman JP; Arming S; Moll JF; Hekele A; Rudy W; Sherman LS; Kreil G; Ponta H; Herrlich P
    Cancer Res; 1996 Jul; 56(13):3134-41. PubMed ID: 8674073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastasis suppression by the standard CD44 isoform does not require the binding of prostate cancer cells to hyaluronate.
    Gao AC; Lou W; Sleeman JP; Isaacs JT
    Cancer Res; 1998 Jun; 58(11):2350-2. PubMed ID: 9622073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of CD44H carbohydrate structure in neuroblastoma adhesive properties.
    Gross N; Balmas K; Beretta Brognara C
    Med Pediatr Oncol; 2001 Jan; 36(1):139-41. PubMed ID: 11464867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of CD44H expression in colon carcinomas reduces tumorigenicity.
    Tanabe KK; Stamenkovic I; Cutler M; Takahashi K
    Ann Surg; 1995 Oct; 222(4):493-501; discussion 501-3. PubMed ID: 7574929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid.
    Ahrens T; Sleeman JP; Schempp CM; Howells N; Hofmann M; Ponta H; Herrlich P; Simon JC
    Oncogene; 2001 Jun; 20(26):3399-408. PubMed ID: 11423990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of functional CD44 hyaluronan receptor on human NMYC-amplified neuroblastoma cells.
    Gross N; Balmas K; Brognara CB
    Cancer Res; 1997 Apr; 57(7):1387-93. PubMed ID: 9102228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional heterogeneity of CD44 molecules in ovarian cancer cell lines.
    Cannistra SA; DeFranzo B; Niloff J; Ottensmeir C
    Clin Cancer Res; 1995 Mar; 1(3):333-42. PubMed ID: 9815989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44.
    Kim HR; Wheeler MA; Wilson CM; Iida J; Eng D; Simpson MA; McCarthy JB; Bullard KM
    Cancer Res; 2004 Jul; 64(13):4569-76. PubMed ID: 15231668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
    Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
    Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
    Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E
    Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYCN-related suppression of functional CD44 expression enhances tumorigenic properties of human neuroblastoma cells.
    Gross N; Balmas Bourloud K; Brognara CB
    Exp Cell Res; 2000 Nov; 260(2):396-403. PubMed ID: 11035936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity.
    Bender FC; Reymond MA; Bron C; Quest AF
    Cancer Res; 2000 Oct; 60(20):5870-8. PubMed ID: 11059785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble CD44 secretion contributes to the acquisition of aggressive tumor phenotype in human colon cancer cells.
    Subramaniam V; Gardner H; Jothy S
    Exp Mol Pathol; 2007 Dec; 83(3):341-6. PubMed ID: 17945213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronate binding assay study of transfected CD44 V4-V7 isoforms into the human gastric carcinoma cell line SC-M1.
    Harn HJ; Shen KL; Liu CA; Ho LI; Yang LS; Yueh KC
    J Pathol; 1998 Mar; 184(3):291-6. PubMed ID: 9614382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of interleukin 15 by human colon cancer cells is associated with induction of mucosal hyperplasia, angiogenesis, and metastasis.
    Kuniyasu H; Ohmori H; Sasaki T; Sasahira T; Yoshida K; Kitadai Y; Fidler IJ
    Clin Cancer Res; 2003 Oct; 9(13):4802-10. PubMed ID: 14581351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
    Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
    Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44 stimulation induces integrin-mediated adhesion of colon cancer cell lines to endothelial cells by up-regulation of integrins and c-Met and activation of integrins.
    Fujisaki T; Tanaka Y; Fujii K; Mine S; Saito K; Yamada S; Yamashita U; Irimura T; Eto S
    Cancer Res; 1999 Sep; 59(17):4427-34. PubMed ID: 10485493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.